Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science




Laura Witte, Ph.D. PA-C



The purpose of the article is to assess whether platelet-rich plasma (PRP) is helpful in reducing the pain of hip osteoarthritis (HOA). Hip osteoarthritis (HOA) affects approximately five percent of people over the age of sixty. The impact of HOA is increasing as our population ages, and obesity rates continue to rise. Conservative treatment options include modified activity levels, physical therapy, and the use of oral medications such as NSAIDs, cyclooxygenase two inhibitors, and opioids. When these options provide suboptimal results, injectable hyaluronic acid (HA) or platelet-rich plasma (PRP) are considered. After injectables, the remaining option is surgical intervention.

Target Audience

The topic of intra-articular injections would be most applicable to orthopedic PAs working in a clinical setting. Primary care PA would also benefit from this information, when considering referrals to orthopedics for painful HOA.

Keywords: platelet-rich plasma, hip osteoarthritis, hip OA therapy, hip OA drug therapy


Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.